ImportRefusal LogoImportRefusal

Laboratoires Boiron

⚠️ Moderate Risk

FEI: 1000261402 • Sainte-Foy-Les-Lyon, Metropole de Lyon • FRANCE

FEI

FEI Number

1000261402

📍

Location

Sainte-Foy-Les-Lyon, Metropole de Lyon

🇫🇷

Country

FRANCE
🏢

Address

20 Route De La Liberation, , Sainte-Foy-Les-Lyon, Metropole de Lyon, France

Moderate Risk

FDA Import Risk Assessment

38.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

13
Total Refusals
6
Unique Violations
4/8/2016
Latest Refusal
12/3/2001
Earliest Refusal

Score Breakdown

Violation Severity
63.2×40%
Refusal Volume
42.5×30%
Recency
0.0×20%
Frequency
9.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

758×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1186×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

4722×

NO ENGLISH

Required label or labeling appears to not be in English in violation of 21 C.F.R. 201.15(c)(1).

161×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

3241×

NO ENGLISH

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).

3331×

LACKS FIRM

The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
4/8/2016
62GBJ99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
Division of Northern Border Imports (DNBI)
6/16/2014
62FBJ99ANTI-INFECTIVE, TOPICAL N.E.C.
75UNAPPROVED
Division of Northern Border Imports (DNBI)
5/16/2014
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
Division of Northeast Imports (DNEI)
5/7/2014
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
472NO ENGLISH
Cincinnati District Office (CIN-DO)
1/5/2010
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
Los Angeles District Office (LOS-DO)
1/6/2009
54AYY99VITAMIN, N.E.C.
324NO ENGLISH
New Orleans District Office (NOL-DO)
5/29/2008
66VAL99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
7/21/2006
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
16DIRECTIONS
333LACKS FIRM
New Orleans District Office (NOL-DO)
7/7/2006
66VAY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Los Angeles District Office (LOS-DO)
2/13/2006
66VAJ99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
2/13/2006
66VBA99MISCELLANEOUS PATENT MEDICINES, ETC.
118NOT LISTED
75UNAPPROVED
New York District Office (NYK-DO)
12/24/2003
66V99MISCELLANEOUS PATENT MEDICINES, ETC.
472NO ENGLISH
75UNAPPROVED
Cincinnati District Office (CIN-DO)
12/3/2001
53IG01DENTIFRICES (AEROSOL, LIQUID, TOOTHPASTES, TOOTHPOWDERS), WITHOUT FLUORIDE (ORAL HYGIENE PRODUCTS)
75UNAPPROVED
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is Laboratoires Boiron's FDA import refusal history?

Laboratoires Boiron (FEI: 1000261402) has 13 FDA import refusal record(s) in our database, spanning from 12/3/2001 to 4/8/2016.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratoires Boiron's FEI number is 1000261402.

What types of violations has Laboratoires Boiron received?

Laboratoires Boiron has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratoires Boiron come from?

All FDA import refusal data for Laboratoires Boiron is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.